As was reported, sleep disorders, excessive daytime sleepiness (EDS) in particular, are frequently manifested in epilepsy; insufficient attention has been devoted to this issue in clinical practice in Georgia. We investigated the frequency of EDS cases among healthy individuals and epilepsy patients. A questionnaire study has been conducted using the Epworth Sleepiness Scale (ESS). A group of 251 volunteers (mean age 33.4 years), including 135 subjects without epilepsy and 116 outpatients with this diagnosis (cryptogenic focal/idiopathic generalized epilepsy without cognitive or brain abnormalities), completed the above questionnaire. The EDS phenomenon was found in 8.9% of healthy individuals and in 17.2% of the patients with epilepsy. This problem was more frequent among the epilepsy patients treated by antiepileptic drugs (AEDs). The prevalence of EDS was higher among men suffering from epilepsy as compared to women with this disease. In the untreated group of the newly diagnosed epilepsy patients, there were more men with EDS than women having this problem. The difference in the EDS occurrence between the two groups of outpatients, treated and untreated with AEDs was statistically insignificant. Unlike the individuals without epilepsy, a gender difference in terms of the EDS frequency was revealed among the newly diagnosed patients.
INTRODUCTION
Disturbances in the sleep-wake cycle are often manifested as daytime sleepiness (DS). Excessive DS (EDS) may result from night sleep deprivation or fragmentation and can be a significant reason for decreased alertness, learning and memory problems, and psychomotor impairment [1] . Because EDS is associated with a greater risk of motor vehicle and work accidents, its assessment is of high importance. Excessive DS is a rather common phenomenon, occurring in 0.5-5.0% of the general populations [2] . Preliminary data on the distribution of sleep-related problems in Georgian youth indicated that EDS is relatively frequently observed in students living in Georgia [3] . This phenomenon is a prominent symptom in various psychiatric and neurological diseases [4] [5] [6] . Interrelation of epilepsy and the sleep mode is a well-known fact [7, 8] ; EDS and sleep disorders are frequently manifested in epilepsy [4] . Epilepsy and its treatment may dramatically affect sleep organization and daytime alertness [9] . Several reports documented a high occurrence of clearly manifested EDS cases among epilepsy patients [4, [9] [10] [11] . This problem is frequently attributed to treatment with antiepileptic drugs (AEDs) [5] and is viewed as an adverse effect of the latter [12] . Moreover, it has been reported that treatment with AEDs may be a reason for a higher risk for sleep disorders in patients with epilepsy; AEDs may directly contribute to DS or insomnia or may exacerbate underlying sleep disorders [9] .
According to the epidemiological research conducted in 1987-1991, epilepsy occurred in 0.57% of the general population of Georgia [13] . The more recent study [14] documented that this rate increased to 0.88%. However, the distribution of DS and/or other sleep-related problems in patients with or without epilepsy has not been studied in Georgia, though relatively more attention has been devoted to this issue recently [15, 16] .
Taking into account that recognition of EDS is an important medical problem, in particular linked with the epilepsy treatment, our study aimed at investigation/evaluation of the EDS occurrence among people living in Georgia. This pilot study is the first part of a longitudinal research concerning the distribution of sleep disorders in epilepsy patients in Georgia. 1 
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METHODS
The retrospective study has been carried out in order to find associations between epilepsy and EDS. Two hundred fifty-one examined subjects (mean age 33.4 years) were categorized as healthy individuals (n = 135, 110 women and 25 men, mean age ± s.d., 34.6 ± ± 11.9 years) and outpatients with epilepsy (n = 116, 72 women and 44 men, 31.9 ± 12.9 years). The subjects with epilepsy were divided into two subgroups: treated (T) patients with AEDs (86 patients, 56 women and 30 men), and untreated (UT) ones (30 newly diagnosed patients, 16 women and 14 men) who have never taken AEDs before but suffered from epileptic seizures before admission to the Institute of Neurology and Neuropsychology (INN, Tbilisi, Georgia). T-group patients took various AEDs (carbamazepine, valproate, phenobarbital, lamotrigine, or combination therapy) at admission. Epilepsy was diagnosed, or the diagnosis had been proved according to the international classifications [17, 18] based on multidisciplinary investigations (consultation with a neurologist/ epileptologist, neuropsychological testing, and EEG recordings) at the INN.
Among 116 consecutive epilepsy outpatients, 95 cases with focal seizures and 21 cases with generalized seizures were identified. All of them had normal, in general, cognition and did not have any CNS abnormalities on CT/MRI. The subjects without epilepsy were in good general health and served as controls. The following demographic and socioeconomic factors were considered: age, gender, education, marital status, and employment (night shift workers were excluded).
All participants were asked to fill out the Epworth Sleepiness Scale (ESS) form [19] (following appropriate onwards-backwards English-Georgian translation), the most frequently used subjective evaluation of EDS. The 8-item ESS is widely used as a way of measuring subjective sleepiness in research and clinical practice [20, 21] . Subjects with the ESS score of eleven or greater were classified as having clinically significant EDS.
Associations for categorical variables were examined by the Pearson χ 2 test; the Student's t test was used for continuous variables [22] . Data analysis was performed using SPSS statistical software, version 13.0.
RESULTS
A clear association between the diagnosis of epilepsy and EDS occurrence was found (χ 2 = 3.91, df-1, n = 251, P = 0.048). Examination of withingroup frequencies showed that about 17.2% (20 out of 116) of patients with epilepsy experienced EDS, as compared to 8.9% (12 out of 135) of individuals without epilepsy, i.e., the occurrence of EDS in epilepsy patients was about two times greater than that in healthy subjects. Among the newly diagnosed patients with epilepsy who have not been treated with AEDs, EDS was detected in 13.3% (4 out of 30 cases; the difference between EDS frequencies in patients and control subjects did not reach the significance level).
A considerable difference was found in the prevalence of EDS between UT-group men (28.6%; 4 out of 14) and healthy men (4.0%; 1 out of 25; χ 2 = 4.85, df-1, n = 116, P = 0.047). None of the women in the UT group had EDS; however, this problem was found in 10% (11 out of 110) of women without epilepsy. Considerable intergender differences were observed in the frequency of EDS in epilepsy patients. The prevalence of EDS was much higher in men (27.3%; 12 out of 44) than in women (8.3%; 6 out of 72; χ 2 =7.50, df-1, n = 116, P = 0.0064). As was mentioned, in subjects without epilepsy, 10.0% women (11 out of 110) and 4.0% men (1 out of 25) had EDS; however, the difference was statistically insignificant. Four out of 30 untreated epilepsy patients (13.3%) and 18 out of 86 patients treated with AEDs (18.6%) were identified as individuals having EDS; however, the difference between these two subgroups was not statistically significant.
In the T group, EDS was revealed in 26.7% (8 out of 30) of men and 10.7% (6 out of 56) of women (the gender difference did not reach the significance level). There was a nearly similar distribution of EDS in treated and untreated men suffering from epilepsy, 26.7% (8 out of 30) and 28.6% (4 out of 14), respectively.
DISCUSSION
In this pilot study, we have evaluated the EDS frequency among healthy individuals and patients with epilepsy living in Georgia, using the ESS [19] . This questionnaire has been proposed as a quick, efficient, and inexpensive measure of the subjective EDS; it is often used for confirmation of EDS in epilepsy patients [4, 10] . We found that EDS (identified according to ESS score >10) is about two times more frequent in epilepsy patients than in individuals free from this pathology. A variety of factors can result in EDS in healthy subjects; yet, a much greater occurrence of EDS in epilepsy patients shows that this disease clearly correlates with the analyzed phenomena. Although EDS was less frequent among subjects without epilepsy as compared to newly diagnosed untreated epilepsy patients (not taking AEDs), this difference was not statistically significant. This fact might be related to the relatively small number of newly diagnosed and examined untreated epilepsy patients who applied to the INN in the course of our investigation.
It is often reported that EDS in epilepsy patients is due to treatment by AEDs, and these patients possess a higher risk for sleep disorders, as treatment with these drugs may directly contribute to DS or insomnia [23, 24] . Using the ESS, a widely used and validated subjective measure of DS [19] , Malow et al [4] reported that 28% of 158 surveyed adult epilepsy patients had an elevated score (higher than 10 points). The results of our study agree to a certain extent with the findings of those authors who have indicated a high prevalence of sleep complaints and EDS in epilepsy patients [4, 10, 11] . Thus, this phenomenon in epilepsy is observed in different countries and among different ethnic groups.
Epilepsy outpatients in Georgia who took AEDs were clearly more predisposed to EDS than subjects without epilepsy. Subjective sleepiness was common in both groups (UT and T) of epilepsy patients, but only a slight trend toward an elevated frequency of EDS was revealed among the patients treated with AEDs.
The results of our study concerning intergender differences in the prevalence of EDS seem to be especially interesting. In particular, it was noted that EDS was more frequent in men than in women suffering from epilepsy (P < 0.05). No significant difference has been observed in EDS occurrence among healthy men and women. However, more than one quarter of male subjects in the UT group (taking no AEDs) were identified as having EDS. Analysis of the data on the EDS distribution among the T-group subjects did not show any gender difference. Our findings on the frequency of EDS in men allow us to state that EDS was less prevalent among men in the control group than among male subjects in the UT or T subgroups (P < 0.05). As for the occurrence of EDS among women, no intergroup differences have been found. An interesting finding was that EDS was noticeably more frequent in men compared to women in all the investigated groups (control, T, and UT).
Thus, the findings of our study on the occurrence of EDS among Georgian people with and without epilepsy allow us to conclude that EDS is a noticeable medical problem in Georgian epilepsy patients. More research is needed to assess the EDS occurrence among epilepsy patients in relation to the treatment strategy, socio-demographic factors, and a sleep-wake schedule or sleep difficulties. Longitudinal studies have to be carried out to investigate this problem, which would allow us to clarify whether EDS is a specific consequence of anti-epileptic therapy, or sleep disorders (insomnia, obstructive sleep apnea, a restless legs syndrome, etc.) frequently coexist with epilepsy with no dependence on the treatment used.
